Market Overview:
The global bacterial conjunctivitis drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of bacterial conjunctivitis, rising awareness about available treatment options, and growing demand for novel therapies. Based on type, the global bacterial conjunctivitis drugs market is segmented into fluoroquinolones, aminoglycosides, macrolides, and others. The fluoroquinolones segment is expected to account for the largest share of the global bacterial conjunctivitis drugs market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to its high efficacy and safety profile. Based on application, the global bacterial conjunctivitis drugs market is divided into infective (viral and bacterial), allergic, and irritant (chemical).
Product Definition:
Bacterial conjunctivitis, also known as pink eye, is a common infection of the eye caused by bacteria. It often results in a pink or red eye, and may cause discharge from the eye.
There are many different types of bacteria that can cause bacterial conjunctivitis. The most common type is chlamydia trachomatis. Other types include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Bacterial conjunctivitis is treated with antibiotics. Treatment usually lasts for 5 to 7 days.
Fluoroquinolones:
The global Fluoroquinolones market is expected to witness significant growth over the forecast period. Fluoroquinolones are a type of antibiotic used to treat bacterial infections. The most commonly known quinolone is Levaquin, which is widely prescribed for ear, urinary tract and respiratory infections as well as being used in some cases of sinusitis and pneumonia.
Aminoglycosides:
Aminoglycosides are a group of antibiotics that are used to treat bacterial infections in the inner ear, brain, and eyes. They may also be used to treat certain other bacterial infections.
Application Insights:
Based on the application, the global market is segmented into infectious (viral and bacterial), allergic, and irritant. The infectious segment dominated the overall market in terms of revenue share in 2017. This can be attributed to increasing travel activities, which has resulted in an increase in incidence of viral infections such as chickenpox and measles that may lead to bacterial conjunctivitis.
The allergic segment is expected to witness significant growth over the forecast period due to rising awareness about allergies among population globally. For instance, according to a study published by Allergy UK magazine online reported that around 12 million people are affected by allergy each year with approximately 2-3% prevalence rate across all age groups globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of bacterial conjunctivitis, increasing awareness about early diagnosis and availability of effective treatment methods for this condition. In addition, presence of key players in this region is also expected to contribute towards growth over the forecast period. For instance, Pfizer Inc., manufacturer of branded pharmaceutical products such as Advil (naproxen) and Aleve (cetirizine), has been developing eye drop formulations since 2012 under brand name OcuSoft gel that are used for treating bacterial conjunctivitis symptoms such as itching, burning sensation and redness associated with infected eyes.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with growing awareness among people about available treatment options for infectious diseases like bacteria-caused bacterial Conjunctivitis or Fluconjunctival Disease (FVD).
Growth Factors:
- Increasing incidence of bacterial conjunctivitis
- Rising demand for ophthalmic drugs and devices
- Growing awareness about eye health and hygiene
- Technological advancements in the field of ophthalmology
- Proliferation of private clinics and hospitals
Scope Of The Report
Report Attributes
Report Details
Report Title
Bacterial Conjunctivitis Drugs Market Research Report
By Type
Fluoroquinolones, Aminoglycosides, Macrolides, Others
By Application
Infective (Viral and Bacterial), Allergic, Irritant (Chemical)
By Companies
Santen Pharmaceutical, Perrigo, Merck, Bayer, Akorn, Santen Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Bacterial Conjunctivitis Drugs Market Report Segments:
The global Bacterial Conjunctivitis Drugs market is segmented on the basis of:
Types
Fluoroquinolones, Aminoglycosides, Macrolides, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infective (Viral and Bacterial), Allergic, Irritant (Chemical)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Santen Pharmaceutical
- Perrigo
- Merck
- Bayer
- Akorn
- Santen Pharmaceutical
Highlights of The Bacterial Conjunctivitis Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fluoroquinolones
- Aminoglycosides
- Macrolides
- Others
- By Application:
- Infective (Viral and Bacterial)
- Allergic
- Irritant (Chemical)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bacterial Conjunctivitis Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bacterial conjunctivitis drugs are medications used to treat bacterial conjunctivitis. These drugs work by killing the bacteria that is causing the infection.
Some of the key players operating in the bacterial conjunctivitis drugs market are Santen Pharmaceutical, Perrigo, Merck, Bayer, Akorn, Santen Pharmaceutical.
The bacterial conjunctivitis drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bacterial Conjunctivitis Drugs Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Bacterial Conjunctivitis Drugs Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Bacterial Conjunctivitis Drugs Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Bacterial Conjunctivitis Drugs Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Bacterial Conjunctivitis Drugs Market Size & Forecast, 2018-2028 4.5.1 Bacterial Conjunctivitis Drugs Market Size and Y-o-Y Growth 4.5.2 Bacterial Conjunctivitis Drugs Market Absolute $ Opportunity
Chapter 5 Global Bacterial Conjunctivitis Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bacterial Conjunctivitis Drugs Market Size Forecast by Type
5.2.1 Fluoroquinolones
5.2.2 Aminoglycosides
5.2.3 Macrolides
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bacterial Conjunctivitis Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bacterial Conjunctivitis Drugs Market Size Forecast by Applications
6.2.1 Infective (Viral and Bacterial)
6.2.2 Allergic
6.2.3 Irritant (Chemical)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bacterial Conjunctivitis Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bacterial Conjunctivitis Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bacterial Conjunctivitis Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Bacterial Conjunctivitis Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bacterial Conjunctivitis Drugs Market Size Forecast by Type
9.6.1 Fluoroquinolones
9.6.2 Aminoglycosides
9.6.3 Macrolides
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bacterial Conjunctivitis Drugs Market Size Forecast by Applications
9.10.1 Infective (Viral and Bacterial)
9.10.2 Allergic
9.10.3 Irritant (Chemical)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bacterial Conjunctivitis Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Bacterial Conjunctivitis Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bacterial Conjunctivitis Drugs Market Size Forecast by Type
10.6.1 Fluoroquinolones
10.6.2 Aminoglycosides
10.6.3 Macrolides
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bacterial Conjunctivitis Drugs Market Size Forecast by Applications
10.10.1 Infective (Viral and Bacterial)
10.10.2 Allergic
10.10.3 Irritant (Chemical)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bacterial Conjunctivitis Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bacterial Conjunctivitis Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bacterial Conjunctivitis Drugs Market Size Forecast by Type
11.6.1 Fluoroquinolones
11.6.2 Aminoglycosides
11.6.3 Macrolides
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bacterial Conjunctivitis Drugs Market Size Forecast by Applications
11.10.1 Infective (Viral and Bacterial)
11.10.2 Allergic
11.10.3 Irritant (Chemical)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bacterial Conjunctivitis Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Bacterial Conjunctivitis Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bacterial Conjunctivitis Drugs Market Size Forecast by Type
12.6.1 Fluoroquinolones
12.6.2 Aminoglycosides
12.6.3 Macrolides
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bacterial Conjunctivitis Drugs Market Size Forecast by Applications
12.10.1 Infective (Viral and Bacterial)
12.10.2 Allergic
12.10.3 Irritant (Chemical)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bacterial Conjunctivitis Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bacterial Conjunctivitis Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bacterial Conjunctivitis Drugs Market Size Forecast by Type
13.6.1 Fluoroquinolones
13.6.2 Aminoglycosides
13.6.3 Macrolides
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bacterial Conjunctivitis Drugs Market Size Forecast by Applications
13.10.1 Infective (Viral and Bacterial)
13.10.2 Allergic
13.10.3 Irritant (Chemical)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bacterial Conjunctivitis Drugs Market: Competitive Dashboard
14.2 Global Bacterial Conjunctivitis Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Santen Pharmaceutical
14.3.2 Perrigo
14.3.3 Merck
14.3.4 Bayer
14.3.5 Akorn
14.3.6 Santen Pharmaceutical